Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Total Current Liabilities (2018 - 2025)

Health Catalyst (HCAT) has disclosed Total Current Liabilities for 8 consecutive years, with $87.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities fell 72.85% year-over-year to $87.9 million, compared with a TTM value of $87.9 million through Sep 2025, down 72.85%, and an annual FY2024 reading of $325.8 million, up 265.98% over the prior year.
  • Total Current Liabilities was $87.9 million for Q3 2025 at Health Catalyst, down from $98.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $339.6 million in Q1 2025 and bottomed at $82.5 million in Q4 2022.
  • Average Total Current Liabilities over 5 years is $167.1 million, with a median of $93.1 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities skyrocketed 414.45% in 2021, then plummeted 72.85% in 2025.
  • Year by year, Total Current Liabilities stood at $93.1 million in 2021, then decreased by 11.33% to $82.5 million in 2022, then rose by 7.91% to $89.0 million in 2023, then soared by 265.98% to $325.8 million in 2024, then plummeted by 73.03% to $87.9 million in 2025.
  • Business Quant data shows Total Current Liabilities for HCAT at $87.9 million in Q3 2025, $98.8 million in Q2 2025, and $339.6 million in Q1 2025.